iPSC Manufacturing Summit

Join us in Boston for the iPSC Manufacturing Summit, the only forum dedicated to optimizing the scalable manufacture of high-quality and consistent iPSCs.

Capture the unmatched potential of these versatile stem cells in regenerative medicine and cell therapy by advancing scale-up, differentiation and quality to reduce variability and ensure stable and robust cell lines.

Gain valuable insights from industry experts, through exclusive talks and discussions, into approaches to transform your manufacturing processes by exploring technology innovations, leveraging automation and AI, evolving analytics and advancing cryopreservation.

Prices:
Drug Developer Pricing - Conference + 2 Workshops: USD 4197.0,
Drug Developer Pricing - Conference + 1 Workshop: USD 3598.0,
Drug Developer Pricing - Conference Only: USD 2999.0,
Solution Provider Pricing - Conference + 2 Workshops: USD 5097.0,
Solution Provider Pricing - Conference + 1 Workshop: USD 4348.0,
Solution Provider Pricing - Conference Only: USD 3599.0,
Academic Pricing - Conference + 2 Workshops: USD 3697.0,
Academic Pricing - Conference + 1 Workshop: USD 3148.0,
Academic Pricing - Conference Only: USD 2599.0

Speakers: Kapil Bharti, Senior Investigator, NIH, Teisha Rowland, Principal Scientist, Umoja Biopharma, Daniel Wang, Assistant Research Professor, City of Hope, Xiaokui Zhang, Chief Scientific Officer, Aspen Neuroscience, Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics, James Dutton, Associate Professor, Stem Cell Institute, University of Minnesota, Yuguo Lei, Associate Professor, Penn State University, Jane Lebkowski, President, Regenerative Patch Technologies, Elizabeth Csaszar, Senior Director, Manufacturing Sciences, Notch Therapeutics, Mary Clare McCorry, Director, Technology and Process Development, ARMI, Takehiko Kaneko MD, Chief Medical Officer and Head of R and D, Heartseed Inc., Stephen Sullivan, Programme Manager and International Liaison Officer, GAiT, Shiv Mistry, Senior Associate Engineer, Century Therapeutics, Nicholas Boyd, Chief Development Officer, Cartherics, Bruno Marques, Executive Director, Process and Product Development, Century Therapeutics, Miguel Forte, Chief Executive Officer, Bone Therapeutics, Richard McFarland, Chief Regulatory Officer, ARMI

Others Details

Brochure: https://go.evvnt.com/1067242-3?pid=6581